Abstract

Retinal prostheses hold the promise of restoring vision in totally blind people. However, a decade of clinical trials highlighted quantitative limitations hampering the possibility of reaching this goal. A key challenge in retinal stimulation is to independently activate retinal neurons over a large portion of the subject’s visual field. Reaching such a goal would significantly improve the perception accuracy in retinal implants’ users, along with their spatial cognition, attention, ambient mapping and interaction with the environment. Here we show a wide-field, high-density and high-resolution photovoltaic epiretinal prosthesis for artificial vision (POLYRETINA). The prosthesis embeds 10,498 physically and functionally independent photovoltaic pixels, allowing for wide retinal coverage and high-resolution stimulation. Single-pixel illumination reproducibly induced network-mediated responses from retinal ganglion cells at safe irradiance levels. Furthermore, POLYRETINA allowed response discrimination with a high spatial resolution equivalent to the pixel pitch (120 µm) thanks to the network-mediated stimulation mechanism. This approach could allow mid-peripheral artificial vision in patients with retinitis pigmentosa.

Highlights

  • Retinal prostheses hold the promise of restoring vision in totally blind people

  • Retinal implants have been predominantly tested in blind patients affected by retinitis pigmentosa, a set of inherited retinal dystrophies causing the progressive loss of retinal photoreceptors, the visual field’s constriction and eventually blindness[14]

  • Our results demonstrated that POLYRETINA could achieve a high spatial resolution in epiretinal stimulation, which is a substantial step forward for artificial vision

Read more

Summary

Introduction

Retinal prostheses hold the promise of restoring vision in totally blind people. a decade of clinical trials highlighted quantitative limitations hampering the possibility of reaching this goal. POLYRETINA allowed response discrimination with a high spatial resolution equivalent to the pixel pitch (120 μm) thanks to the network-mediated stimulation mechanism This approach could allow mid-peripheral artificial vision in patients with retinitis pigmentosa. Onethird of the users of the Argus® II epiretinal prosthesis (the most implanted so far) declared that the device had a neutral impact on their quality of life after three years[19]. This discouragement can be attributed to quantitative limitations in artificial vision provided by retinal implants[18]. The coarse visual resolution offered by the device

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call